BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
The effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. ✅
Go to Publication ✅
BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 14 Issue Pages: 386 Pub: 2014 Oct 10 Epub: 2014 Oct 10 Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Zhao T , Qu H , Huang J , Wu Y , Gu R , |
|
|
The effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. ✅
Go to Publication ✅
BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 14 Issue Pages: 386 Pub: 2014 Oct 10 Epub: 2014 Oct 10 Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Zhao T , Qu H , Huang J , Wu Y , Gu R , |
|
|
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95 Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R , |
|
|
Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. ✅
Go to Publication ✅
PeerJ (PeerJ ) Vol: 1 Issue Pages: e32 Pub: 2013 Epub: 2013 Feb 26 Authors Lahti L , Salonen A , Kekkonen RA , Salojärvi J , Jalanka-Tuovinen J , Palva A , Orešic M , de Vos WM , |
|
|
Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. ✅
Go to Publication ✅
PeerJ (PeerJ ) Vol: 1 Issue Pages: e32 Pub: 2013 Epub: 2013 Feb 26 Authors Lahti L , Salonen A , Kekkonen RA , Salojärvi J , Jalanka-Tuovinen J , Palva A , Orešic M , de Vos WM , |
|
|
Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. ✅
Go to Publication ✅
PeerJ (PeerJ ) Vol: 1 Issue Pages: e32 Pub: 2013 Epub: 2013 Feb 26 Authors Lahti L , Salonen A , Kekkonen RA , Salojärvi J , Jalanka-Tuovinen J , Palva A , Orešic M , de Vos WM , |
|
|
Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. ✅
Go to Publication ✅
PeerJ (PeerJ ) Vol: 1 Issue Pages: e32 Pub: 2013 Epub: 2013 Feb 26 Authors Lahti L , Salonen A , Kekkonen RA , Salojärvi J , Jalanka-Tuovinen J , Palva A , Orešic M , de Vos WM , |
|
|
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. ✅
Go to Publication ✅
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322 Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO , |
|
|
Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 10 Issue 7 Pages: Pub: 2022 Jul 21 Epub: 2022 Jul 21 Authors Gupta H , Kim SH , Kim SK , Han SH , Kwon HC , Suk KT , |
|
|
Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 10 Issue 7 Pages: Pub: 2022 Jul 21 Epub: 2022 Jul 21 Authors Gupta H , Kim SH , Kim SK , Han SH , Kwon HC , Suk KT , |
|
|
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 15460 Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Aktas B , Aslim B , Ozdemir DA , |
|
|
Lactobacillus rhamnosus NKU FL1-8 Isolated from Infant Feces Ameliorates the Alcoholic Liver Damage by Regulating the Gut Microbiota and Intestinal Barrier in C57BL/6J Mice. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 13 Pages: Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Liu H , Fan D , Wang J , Wang Y , Li A , Wu S , Zhang B , Liu J , Wang S , |
|
|
Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 12 Issue 11 Pages: Pub: 2023 Nov 11 Epub: 2023 Nov 11 Authors Alsholi DM , Yacoub GS , Rehman AU , Ullah H , Khan AI , Deng T , Siddiqui NZ , Alioui Y , Farooqui NA , Elkharti M , Li Y , Wang L , Xin Y , |
|
|
Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 12 Issue 11 Pages: Pub: 2023 Nov 11 Epub: 2023 Nov 11 Authors Alsholi DM , Yacoub GS , Rehman AU , Ullah H , Khan AI , Deng T , Siddiqui NZ , Alioui Y , Farooqui NA , Elkharti M , Li Y , Wang L , Xin Y , |
|
|
Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 12 Issue 11 Pages: Pub: 2023 Nov 11 Epub: 2023 Nov 11 Authors Alsholi DM , Yacoub GS , Rehman AU , Ullah H , Khan AI , Deng T , Siddiqui NZ , Alioui Y , Farooqui NA , Elkharti M , Li Y , Wang L , Xin Y , |
|
|
Lactobacillus rhamnosus TR08 Improves Dyslipidemia in Mice Fed with a High Fat Diet by Regulating the Intestinal Microbiota, Reducing Systemic Inflammatory Response, and Promoting Sphingomholipid Metabolism. ✅
Go to Publication ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 21 Pages: Pub: 2022 Oct 29 Epub: 2022 Oct 29 Authors Feng X , Ding L , Ma G , Zhang Y , Sun Y , Li Z , Tao X , Ali A , Wang D , Wu L , |
|
|
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 772532 Pub: 2021 Epub: 2021 Dec 14 Authors Gao G , Ma T , Zhang T , Jin H , Li Y , Kwok LY , Zhang H , Sun Z , |
|
|
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 772532 Pub: 2021 Epub: 2021 Dec 14 Authors Gao G , Ma T , Zhang T , Jin H , Li Y , Kwok LY , Zhang H , Sun Z , |
|
|
Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 11 Pages: 5171-5186 Pub: 2021 Jun 8 Epub: Authors Pang B , Jin H , Liao N , Li J , Jiang C , Shao D , Shi J , |
|
|
Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 11 Pages: 5171-5186 Pub: 2021 Jun 8 Epub: Authors Pang B , Jin H , Liao N , Li J , Jiang C , Shao D , Shi J , |
|
|
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , |
|
|
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , |
|
|
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , |
|
|
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. ✅
Journal of biological regulators and homeostatic agents (J Biol Regul Homeost Agents ) Vol: 28 Issue 4 Pages: 743-52 Pub: 2014 Oct-Dec Epub: Authors Orsi CF , Sabia C , Ardizzoni A , Colombari B , Neglia RG , Peppoloni S , Morace G , Blasi E , |
|
|
Anticandidal and Antibiofilm Effect of Synbiotics including Probiotics and Inulin-Type Fructans. ✅
Go to Publication ✅
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 11 Issue 8 Pages: Pub: 2022 Aug 21 Epub: 2022 Aug 21 Authors García-Gamboa R , Domínguez-Simi M , Gradilla-Hernández MS , Bravo J , Moya A , Ruiz-Álvarez B , González-Avila M , |
|
|
Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity. ✅
Go to Publication ✅
Nature communications (Nat Commun ) Vol: 13 Issue 1 Pages: 3192 Pub: 2022 Jun 9 Epub: 2022 Jun 9 Authors Alonso-Roman R , Last A , Mirhakkak MH , Sprague JL , Möller L , Großmann P , Graf K , Gratz R , Mogavero S , Vylkova S , Panagiotou G , Schäuble S , Hube B , Gresnigt MS , |
|
|
Multi-Strain Probiotics Alleviate Alcoholic Liver Disease Via Microbiota-Metabolism Axis: A Randomized Controlled Study. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2025 Nov 3 Epub: 2025 Nov 3 Authors Feng J , Wu J , Zhang M , Chen W , Zhao J , Lv Y , Lai R , Fang S , Li Y , |
|
|
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 222 Issue Pt 2 Pages: 117757 Pub: 2025 Dec Epub: 2025 Oct 31 Authors Vaccalluzzo A , Celano G , Calabrese FM , Pino A , Caggia C , De Angelis M , Randazzo CL , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
